PROCEPT BioRobotics (PRCT) Non Operating Interest Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Non Operating Interest Expenses for 7 consecutive years, with $842000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 5.92% year-over-year to $842000.0 in Q2 2026; TTM through Jun 2026 was $3.5 million, a 10.51% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 14.29% from the prior year.
• Non Operating Interest Expenses was $842000.0 for Q2 2026 at PROCEPT BioRobotics, up from $818000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $1.5 million in Q3 2022 and troughed at $818000.0 in Q1 2026.
• A 5-year average of $1.0 million and a median of $967000.0 in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 39.86% in 2022 and rose 29.91% in 2023, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $866000.0 in 2022, then rose by 29.91% to $1.1 million in 2023, then retreated by 13.87% to $969000.0 in 2024, then slipped by 7.74% to $894000.0 in 2025, then fell by 5.82% to $842000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $842000.0 (Q2 2026), $818000.0 (Q1 2026), and $894000.0 (Q4 2025), per Business Quant data.